크라이오젠 프리 MRI 스캐너 시장 : 세계 예측(2026-2032년)

The Cryogen-free MRI Scanner Market is projected to grow by USD 2.85 billion at a CAGR of 10.07% by 2032.

Cryogen-Free MRI Scanners: Executive Summary

Cryogen-free MRI scanners use technologies such as sealed magnet systems, permanent magnets, or reduced-helium designs to support magnetic resonance imaging without routine dependence on bulk liquid helium. Their relevance is increasing as healthcare providers seek simpler installation, lower infrastructure requirements, and greater resilience in settings where helium logistics, quench management, or specialized facility design create operational challenges.

Infrastructure Simplicity Is Reshaping MRI Deployment

The principal transformation is a shift from conventional superconducting systems toward designs that can reduce siting complexity and operational dependence on cryogenic infrastructure. This can support deployment in outpatient facilities, community hospitals, mobile environments, and regions with constrained engineering resources. Adoption still depends on image quality, field strength, workflow integration, serviceability, regulatory clearance, and compatibility with clinical protocols.

Artificial Intelligence Extends the Value of Cryogen-Free Systems

Artificial intelligence can strengthen the clinical and operational case for cryogen-free MRI by enabling accelerated image reconstruction, denoising, artifact reduction, protocol selection, and workflow automation. These tools may help compensate for limitations associated with lower-field or compact architectures, although performance must be validated across anatomies, patient groups, and clinical use cases. Successful implementation also requires representative training data, cybersecurity controls, explainable outputs, and radiologist oversight.

Regional Insights: Deployment Priorities Differ by Healthcare Context

North America emphasizes outpatient access, replacement of aging equipment, workflow efficiency, and regulatory compliance. Europe places strong attention on energy use, sustainability, decentralized care, and procurement standards. Asia-Pacific combines advanced hospital demand with substantial needs for scalable access across urban and remote settings. Latin America may value reduced installation and maintenance complexity where infrastructure varies widely. The Middle East is characterized by investment in advanced healthcare facilities and centralized specialist services, while Africa presents opportunities for robust, lower-infrastructure imaging solutions alongside challenges involving procurement, training, uptime, and technical support.

Group Insights: Policy and Alliance Structures Shape Adoption

ASEAN economies may benefit from compact systems that support distributed diagnostic capacity across diverse health infrastructures. BRICS members span large and varied healthcare systems, making affordability, domestic technical capability, and service networks important considerations. The European Union emphasizes harmonized safety, sustainability, and medical-device requirements. G7 markets generally prioritize clinical evidence, interoperability, cybersecurity, and total cost of ownership. GCC countries often focus on technologically advanced hospitals and centralized procurement, while NATO members may additionally value resilient medical infrastructure, deployability, and continuity of care during disruptions.

Country Insights: Local Conditions Determine the Best Use Cases

Australia may prioritize regional access and dependable service logistics; Brazil and Mexico may benefit from lower-infrastructure deployment models across geographically dispersed systems. Canada and the United States place emphasis on outpatient imaging, replacement cycles, and integration with established clinical networks. China and India combine sophisticated tertiary-care demand with opportunities to expand access beyond major urban centers. Japan and South Korea emphasize compact engineering, workflow quality, and technology integration. France, Germany, Italy, Spain, and the United Kingdom are shaped by public procurement, sustainability objectives, clinical validation, and health-system interoperability. Russia's context includes geographic scale, equipment resilience, and serviceability considerations.

Action Priorities for MRI Industry Leaders

Leaders should define target clinical workflows before selecting magnet architecture, then validate image quality against relevant diagnostic protocols rather than relying on installation simplicity alone. Product strategies should emphasize transparent total-cost analysis, predictable uptime, remote diagnostics, technician training, and modular service models. Partnerships with hospitals and radiology networks can generate real-world evidence, while AI features should be introduced with governance, auditability, and human review. Regional commercialization plans should account for regulatory pathways, procurement practices, power reliability, import requirements, and local support capacity.

Research Methodology for the Executive Summary

This summary applies a qualitative, evidence-oriented framework to the cryogen-free MRI scanner landscape. It examines technology characteristics, clinical workflow requirements, infrastructure implications, AI applications, regulatory considerations, and adoption conditions across the specified regions, groups, and countries. The assessment distinguishes established operational considerations from potential applications and avoids unsupported quantitative claims, market estimates, forecasts, company references, and market-share statements.

Conclusion: Practicality and Clinical Performance Must Advance Together

Cryogen-free MRI scanners address meaningful constraints associated with conventional MRI installation and cryogenic operations, particularly where space, infrastructure, helium access, or service continuity matter. Their long-term relevance will depend on demonstrated diagnostic performance, dependable uptime, responsible AI integration, and strong local support. Industry leaders that align product design with clinical needs and regional operating realities will be better positioned to expand access without compromising safety or image quality.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cryogen-free MRI Scanner Market, by Field Strength

• 7.1. Introduction
• 7.2. High Field
  • 7.2.1. 1.5T
  • 7.2.2. 3T
• 7.3. Low Field
  • 7.3.1. 0.3T
  • 7.3.2. 0.5T
• 7.4. Medium Field

8. Cryogen-free MRI Scanner Market, by System Type

• 8.1. Introduction
• 8.2. Closed Bore
  • 8.2.1. 60cm Bore
  • 8.2.2. 70cm Bore
• 8.3. Open Bore
  • 8.3.1. C Shape
  • 8.3.2. U Shape

9. Cryogen-free MRI Scanner Market, by Application

• 9.1. Introduction
• 9.2. Clinical
  • 9.2.1. Cardiology
  • 9.2.2. Neurology
  • 9.2.3. Oncology
• 9.3. Industrial
• 9.4. Research
  • 9.4.1. Academic Research
  • 9.4.2. Pharmaceutical

10. Cryogen-free MRI Scanner Market, by End User

• 10.1. Introduction
• 10.2. Academic Institutions
  • 10.2.1. Research Institutes
  • 10.2.2. Universities
• 10.3. Diagnostic Centers
  • 10.3.1. Imaging Centers
  • 10.3.2. Outpatient Centers
• 10.4. Hospitals
  • 10.4.1. Private Hospitals
  • 10.4.2. Teaching Hospitals

11. Cryogen-free MRI Scanner Market, by Sales Channel

• 11.1. Introduction
• 11.2. Online
• 11.3. Offline

12. Cryogen-free MRI Scanner Market, by Region

• 12.1. Introduction
• 12.2. Asia-Pacific
• 12.3. North America
• 12.4. Latin America
• 12.5. Europe
• 12.6. Middle East
• 12.7. Africa

13. Cryogen-free MRI Scanner Market, by Group

• 13.1. Introduction
• 13.2. ASEAN
• 13.3. GCC
• 13.4. European Union
• 13.5. BRICS
• 13.6. G7
• 13.7. NATO

14. Cryogen-free MRI Scanner Market, by Country

• 14.1. Introduction
• 14.2. United States
• 14.3. Canada
• 14.4. Mexico
• 14.5. Brazil
• 14.6. United Kingdom
• 14.7. Germany
• 14.8. France
• 14.9. Russia
• 14.10. Italy
• 14.11. Spain
• 14.12. China
• 14.13. India
• 14.14. Japan
• 14.15. Australia
• 14.16. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. Market Concentration Analysis, 2025
  • 15.2.1. Concentration Ratio (CR)
  • 15.2.2. Herfindahl Hirschman Index (HHI)
• 15.3. Recent Developments & Impact Analysis, 2025
• 15.4. Product Portfolio Analysis, 2025
• 15.5. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Advanced Magnetic Resonance GmbH
• 16.2. Agilent Technologies Inc.
• 16.3. Analogic Corporation
• 16.4. Aspect Imaging Ltd.
• 16.5. Bruker Corporation
• 16.6. Canon Medical Systems Corporation
• 16.7. Cryomagnetics, Inc.
• 16.8. Curium Pharma
• 16.9. Esaote S.p.A.
• 16.10. EVO Microwave Electronics Ltd.
• 16.11. Fujifilm Holdings Corporation
• 16.12. GE Healthcare
• 16.13. Hitachi, Ltd.
• 16.14. Hyperfine Research Inc.
• 16.15. Jastec Co., Ltd.
• 16.16. Magnetica Materials Pty Ltd
• 16.17. Magritek Ltd.
• 16.18. Medtronic plc
• 16.19. MR Solutions Ltd.
• 16.20. MR Technology Co., Ltd.
• 16.21. Neuroscience GmbH
• 16.22. Niumag Corporation
• 16.23. Oxford Instruments plc
• 16.24. Phenix Technology Co., Ltd.
• 16.25. Philips Healthcare
• 16.26. Shanghai United Imaging Healthcare Co., Ltd.
• 16.27. Siemens Healthineers AG
• 16.28. Synaptive Medical
• 16.29. Teledyne Reson iCOUNT Inc.
• 16.30. Toshiba Medical Systems Corporation

17. Key Experts